Fig. 9
From: Comprehensive analyses reveal the carcinogenic and immunological roles of ANLN in human cancers
Validation of ANLN mRNA and protein expression in gastrointestinal malignancies. A–C qRT-PCR analysis detected the ANLN mRNA expression relative to GAPDH in colorectal cancer, gastric cancer, and hepatocellular carcinoma cell lines. D–G The Human Protein Atlas database validated the ANLN protein expression in liver cancer, colorectal cancer, stomach cancer, pancreatic cancer and corresponding normal tissues. *P < 0.05